Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women
Glucagon-like peptide-1 (GLP-1), an incretin hormone, plays an important role in regulating glucose homeostasis. In this study, the applicability of circulating GLP-1 levels as an early indicator of metabolic syndrome (MetS) risk was examined. Women without diagnosed diseases were grouped according...
Main Authors: | Min Joo Seon, So Yoon Hwang, Yujeong Son, Juhyun Song, Oh Yoen Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/3/865 |
Similar Items
-
GLP-1 effects on pancreatic b-cell lines
by: Sinclair, Elaine M.
Published: (2002) -
Effects of Fasting on Glucagon-like peptide-1 hormone (GLP-1), and Lipid Profile Indices in Obese and Thin Women
by: Shahrbanoo Haghighi, et al.
Published: (2019-03-01) -
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
by: Marta Seghieri, et al.
Published: (2018-11-01) -
The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date
by: Antza C, et al.
Published: (2019-08-01) -
Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
by: Young-Kook Kim, et al.
Published: (2020-08-01)